Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Avochato offers HIPAA compliant SMS messaging


SAN FRANCISCO, April 21, 2021 /PRNewswire/ -- Avochato today announced a HIPAA compliant SMS messaging solution. It offers additional layers of security that allow healthcare companies to communicate with patients over SMS while following HIPAA requirements.

"Avochato is elevating data privacy and security measures to meet the needs of our customers. HIPAA compliance is a milestone and a commitment to providing trusted messaging solutions for customers and patients, " says Alex De Simone, co-founder and CEO at Avochato.

Features and benefits of Avochato's HIPAA compliant solution include:

HIPAA compliant messaging is available today to all Avochato customers. For more information, visit www.avochato.com/hipaa .

About Avochato: People prefer to communicate over messaging? but businesses are built around legacy technology like email and phone. Avochato upgrades its customers to messaging, delivering a better customer experience and driving increased customer lifetime value. Recently named a category leader and Top 50 Product on G2 Crowd, Avochato serves thousands of organizations ranging from small businesses to Fortune 100 leaders.

SOURCE Avochato


These press releases may also interest you

at 19:30
Astellas Pharma Inc....

at 19:15
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 18:00
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:45
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...

at 17:44
United Breast Cancer Foundation (UBCF) is proud to host a heartfelt event dedicated to honor the memory of Audrey Beverly Christy Mastroianni, a remarkable Rhode Island woman who bravely battled breast cancer. The "Gifts of Comfort and Hope" Mattress...



News published on and distributed by: